Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Cytecare Hospitals

Verified
Source: Site record.

Basic Information

Site Overview

Source: Human-provided.

Cytecare Hospitals is a comprehensive cancer care and multispecialty hospital located in Yelahanka, Bengaluru, Karnataka. The hospital provides advanced cancer screening, diagnosis, and treatment services, with expertise across medical, surgical, and radiation oncology. Its Oncology Centre of Excellence covers areas such as breast, gastrointestinal, head and neck, gynecological, pediatric, neuro, uro, and hematologic cancers, along with CAR-T cell therapy, bone marrow transplantation, interventional oncology, and palliative care. Cytecare also emphasizes clinical research and evidence-based treatment, while offering diagnostic services including PET-CT, nuclear medicine, pathology, biopsy, radiology, and endoscopy

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Human-provided. Cancer treatment center
Source: Human-provided. Health consultant
Source: Human-provided. Private hospital
Source: Trial-derived.
7Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
2Active Trials
Source: Trial-derived.
4Completed Trials
Source: Trial-derived.
9Unique Conditions
Source: Trial-derived.
7Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Advanced Solid Tumor (1)Source: Trial-derived. Breast Cancer (1)Source: Trial-derived. Leukemia, Lymphocytic, Chronic, B-Cell (1)Source: Trial-derived. Lymphoma (1)Source: Trial-derived. Lymphoma, Mantle-Cell (1)Source: Trial-derived. Multiple Myeloma (1)Source: Trial-derived. Relapsed Malignant Solid Neoplasm (1)Source: Trial-derived. Relapsed Refractory Multiple Myeloma (1)

Sponsors

Source: Trial-derived. Johnson & Johnson Private Limited (2)Source: Trial-derived. Amgen (1)Source: Trial-derived. Aurigene Discovery Technologies Limited (1)Source: Trial-derived. EirGenix, Inc. (1)Source: Trial-derived. Glenmark Specialty S.A. (1)Source: Trial-derived. Indian Society of Critical Care Medicine (1)Source: Trial-derived. Tata Memorial Centre (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase I
Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 8

Principal investigators

Source: Human-provided. 2

Study coordinators

Source: Human-provided. 3

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom